Comparing Gamunex-C vs Privigen
| Gamunex-C (immune globulin intravenous and subcutaneous) | Privigen (immune globulin intravenous) |
|
|---|
| Gamunex-C (immune globulin intravenous and subcutaneous) | Privigen (immune globulin intravenous) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Primary Immunodeficiency Syndrome, Immune Thrombocytopenia. Gamunex-C may also be used for purposes not listed in this... View more |
Prescription only
Prescribed for Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Immune Thrombocytopenia, Primary Immunodeficiency Syndrome. Privigen may also be used for purposes not listed in this medication guide. View more |
Related suggestions Primary Immunodeficiency Syndrome
Immune Thrombocytopenia
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Popular comparisons
|
|||||||||||||||
| More about Gamunex-C (immune globulin intravenous and subcutaneous) | More about Privigen (immune globulin intravenous) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Gamunex-C has an average rating of 8.2 out of 10 from a total of 13 ratings on Drugs.com. 69% of reviewers reported a positive effect, while 8% reported a negative effect. |
Privigen has an average rating of 7.0 out of 10 from a total of 6 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 17% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Gamunex-C side effects |
View all Privigen side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Gamunex-C prices |
View all Privigen prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other immune globulin intravenous and subcutaneous brands include: Gammagard Liquid, Gammaked | Other immune globulin intravenous brands include: Alyglo, Asceniv, Bivigam, Carimune NF, Flebogamma, Gammagard S/D, Gammaplex, Octagam, Panzyga, Yimmugo View more | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
857.76 hours |
576 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 105 drugs are known to interact with Gamunex-C:
|
A total of 105 drugs are known to interact with Privigen:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.